z-logo
open-access-imgOpen Access
Influence of interferon‐γ administration on the severity of experimental group B streptococcal arthritis
Author(s) -
Puliti Manuela,
Von Hunolstein Christina,
Bistoni Francesco,
Mosci Paolo,
Orefici Graziella,
Tissi Luciana
Publication year - 2000
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/1529-0131(200012)43:12<2678::aid-anr7>3.0.co;2-a
Subject(s) - medicine , group a , arthritis , group b , group (periodic table) , immunology , administration (probate law) , interferon , chemistry , political science , organic chemistry , law
Objective To assess the effect of interferon‐γ (IFNγ) administration on the evolution of systemic infection and septic arthritis induced by group B streptococci (GBS) in mice. Methods CD1 mice were inoculated intravenously with arthritogenic strain 1/82 of type IV GBS. Exogenous murine IFNγ or anti‐IFNγ monoclonal antibodies were administered intravenously either 2 hours (−2 hours) before or 18 hours after infection with 1 × 10 7 GBS. Mice were monitored daily for survival and for signs of arthritis. In a subsequent set of experiments, mice were killed at selected times for examination of bacterial clearance, joint histopathology, and cytokine production. Results Mortality in mice treated with IFNγ at −2 hours was 100%, compared with 20% in those treated at 18 hours and with 40% in controls. As indicated by the arthritis score, mice treated with IFNγ at −2 hours developed early and more severe arthritis, whereas those treated at 18 hours had milder arthritis compared with infected controls. Less severe joint pathology in the mice treated with IFNγ at 18 hours correlated with low levels of interleukin‐6 (IL‐6) and IL‐1β and a low bacterial load in the joints, whereas rapid onset and worsening of articular lesions in those treated at −2 hours corresponded to early and sustained levels of IL‐6. Conclusion The findings of this study demonstrate that the effects mediated by IFNγ on GBS‐induced arthritis may be detrimental or beneficial, depending on the time of administration of IFNγ in relation to infection with the antigen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here